<p>OR: odds ratio; ER: estrogen receptor; PR: progesterone receptor; Her-2: human epidermal growth factor receptor 2.</p><p>Results of the meta-analysis of increased EZH2 expression and clinicopathological features of four types of cancer.</p
Introduction: Estrogen receptor-a (ER) and human epidermal growth factor receptor 2 (HER2) positivit...
Background: Breast cancers lacking the estrogen receptor ( ER) can be distinguished from other breas...
Background: In breast cancer, little is known about the consequences of co-expression of ER alpha wi...
Farnaz Boostani,1 Roya Dolatkhah,1 Ashraf Fakhrjou,2 Faris Farassati,3 Zohreh Sanaat1 1Hematology a...
The characterization of breast cancer according to its proliferative activity and the expression of ...
Chemotherapy, endocrine therapy and molecular targeted therapy are vital means in the treatment of m...
Introduction: Breast cancer is a multifactorial disease as a result of interaction between ge- netic...
ABSTRACTIntroduction: Breast cancer is a multifactorial disease as a result of interaction between g...
Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to exp...
Background: Recent studies have shown that the expression status of hormone receptors and human epid...
In MBC, increased mRNA levels of Enhancer of Zeste Homolog 2 (EZH2) have been shown to be associated...
Full list of author information is available at the end of the articleunder the curve (AUC) ≥ 0.9). ...
Objective: Four breast cancer subtypes defined by immunohistochemistry (IHC) expression of estrogen ...
BACKGROUND: The discordance in oestrogen receptor (ER), progesterone receptor (PgR) and human epide...
Background: Enhancer of zeste homolog 2 (EZH2) is a polycomb-group protein that is involved in stem ...
Introduction: Estrogen receptor-a (ER) and human epidermal growth factor receptor 2 (HER2) positivit...
Background: Breast cancers lacking the estrogen receptor ( ER) can be distinguished from other breas...
Background: In breast cancer, little is known about the consequences of co-expression of ER alpha wi...
Farnaz Boostani,1 Roya Dolatkhah,1 Ashraf Fakhrjou,2 Faris Farassati,3 Zohreh Sanaat1 1Hematology a...
The characterization of breast cancer according to its proliferative activity and the expression of ...
Chemotherapy, endocrine therapy and molecular targeted therapy are vital means in the treatment of m...
Introduction: Breast cancer is a multifactorial disease as a result of interaction between ge- netic...
ABSTRACTIntroduction: Breast cancer is a multifactorial disease as a result of interaction between g...
Novel biomarkers are of particular interest for predicting cancer prognosis. This study aimed to exp...
Background: Recent studies have shown that the expression status of hormone receptors and human epid...
In MBC, increased mRNA levels of Enhancer of Zeste Homolog 2 (EZH2) have been shown to be associated...
Full list of author information is available at the end of the articleunder the curve (AUC) ≥ 0.9). ...
Objective: Four breast cancer subtypes defined by immunohistochemistry (IHC) expression of estrogen ...
BACKGROUND: The discordance in oestrogen receptor (ER), progesterone receptor (PgR) and human epide...
Background: Enhancer of zeste homolog 2 (EZH2) is a polycomb-group protein that is involved in stem ...
Introduction: Estrogen receptor-a (ER) and human epidermal growth factor receptor 2 (HER2) positivit...
Background: Breast cancers lacking the estrogen receptor ( ER) can be distinguished from other breas...
Background: In breast cancer, little is known about the consequences of co-expression of ER alpha wi...